Top

International Urogynecology Journal

Published in:

01-03-2011 | Original Article

Quality of life after periurethral injection with polyacrylamide hydrogel for stress urinary incontinence

Authors: Gerda Trutnovsky, Karl Tamussino, Elfriede Greimel, Vesna Bjelic-Radisic

Published in: International Urogynecology Journal | Issue 3/2011

Abstract

Introduction and hypothesis

The purpose of this observational study was to examine the effect of periurethral injections with polyacrylamide hydrogel (PAHG) on quality of life (QoL) in selected patients with stress urinary incontinence (SUI).

Methods

Fifty-four women with comorbidities or other reasons precluding other surgery received PAHG for SUI. Patient-reported outcomes were assessed with the “Incontinence Outcome Questionnaire” (IOQ) 9 months postoperatively. The IOQ is a 27-item, condition-specific instrument that assesses patient-reported outcomes after incontinence surgery.

Results

Forty-two women (78%) completed the questionnaire. Responses ranged from considerable (40%) and slight improvement (21%) to no change (29%) and worsening of symptoms (10%).

Conclusion

Periurethral injections with PAHG are likely to provide relief of symptoms and improvement in QoL.

Rortveit G, Daltveit AK, Hannestad YS, Hunskaar S, Norwegian EPINCONT Study (2003) Urinary incontinence after vaginal delivery or cesarean section. N Engl J Med 348:900–907CrossRefPubMed

Tennstedt SL, FitzGerald MP, Nager C, Xu Y, Zimmern P, Kraus S, for the Urinary Incontinence Treatment Network et al (2007) Quality of life in women with stress urinary incontinence. Int Urogynecol J 18:543–549CrossRef

Gil KM, Somerville AM, Cichowski S, Savitski JL (2009) Distress and quality of life characteristics associated with seeking surgical treatment for stress urinary incontinence. Health Qual Life Outcomes 7:8CrossRefPubMed

Chapple CR, Brubaker L, Haab F, van Kerrebroeck P, Robinson D (2007) Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy. Int Urogynecol J 18:199–205CrossRef

Shamliyan TA, Kane RL, Wyman J, Wilt TJ (2008) Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 148:459–473PubMed

Tamussino K, Hanzal E, Kolle D, Ralph G, Riss P (2001) Tension-free vaginal tape operation: results of the Austrian registry. Obstet Gynecol 98:732–736CrossRefPubMed

Keegan PE, Atiemo K, Cody J, McClinton S, Pickard R (2007) Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 3:CD003881PubMed

Kotb AF, Campeau L, Corcos J (2009) Urethral bulking agents: techniques and outcomes. Curr Urol Rep 10:396–400CrossRefPubMed

Schulz JA, Nager CW, Stanton SL, Baessler K (2003) Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections. Int Urogynecol J 15:261–265

10.

Tamanini JT, D’Ancona CAL, Tadini V, Netto NR (2003) Macroplastique implantation system for the treatment of female stress urinary incontinence. J Urol 169:2229–2233CrossRefPubMed

11.

Lose G, Mouritsen L, Nielsen JB (2006) A new bulking agent (polyacrylamide hydrogel) for treating stress urinary incontinence in women. BJU Int 98:100–104CrossRefPubMed

12.

Corcos J, Collet JP, Shapiro S, Herschorn S, Radomski SB, Schick E et al (2005) Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. Urology 65:898–904CrossRefPubMed

13.

Maher CF, O'Reilly BA, Dwyer PL, Carey MP, Cornish A, Schluter P (2005) Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG 112:797–801CrossRefPubMed

14.

Klarskov N, Lose G (2008) Urethral injection therapy: what is the mechanism of action? Neurourol Urodyn 27:789–792CrossRefPubMed

15.

Bjelic-Radisic V, Dorfer M, Tamussino K, Frudinger A, Kern P, Winter R et al (2007) The Incontinence Outcome Questionnaire: an instrument for assessing patient-reported outcomes after surgery for stress urinary incontinence. Int Urogynecol J 18:1139–1149CrossRef

16.

Liu HL, Cheung WY (2010) Complications of polyacrylamide hydrogel (PAAG) injection in facial augmentation. J Plast Reconstr Aesthet Surg 63:e9–e12CrossRefPubMed

17.

Bjelic-Radisic V, Dorfer M, Greimel E, Frudinger A, Tamussino K, Winter R (2006) Quality of life and continence 1 year after the tension-free vaginal tape operation. Am J Obstet Gynecol 195:1784–1788CrossRefPubMed

Title: Quality of life after periurethral injection with polyacrylamide hydrogel for stress urinary incontinence
Authors: Gerda Trutnovsky
Karl Tamussino
Elfriede Greimel
Vesna Bjelic-Radisic
Publication date: 01-03-2011
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 3/2011
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-010-1296-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Quality of life after periurethral injection with polyacrylamide hydrogel for stress urinary incontinence

Abstract

Introduction and hypothesis

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction and hypothesis

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2011

Five-year outcome of uterus sparing surgery for pelvic organ prolapse repair: a single-center experience

Measuring the effect of antimuscarinics in the bladder

Is standardised vaginal sacrospinous ligament fixation a safe teaching procedure for residents?

Evaluation of safety and efficacy of single-incision mid-urethral short tape procedure (MiniArc™ tape) for stress urinary incontinence under local anaesthesia

Can artificial urinary sphincter be an effective salvage option in women following failed anti-incontinence surgery?

In vitro and in vivo assessment of silver-coated polypropylene mesh to prevent infection in a rat model